CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells

CD40L has a well-established role in enhancing the immunostimulatory capacity of normal and malignant B cells, but a formulation suitable for clinical use has not been widely available. Like other TNF family members, in vivo and in vitro activity of CD40L requires a homotrimeric configuration, and g...

詳細記述

保存先:
書誌詳細
主要な著者: Naito, Masayasu, Hainz, Ursula, Burkhardt, Ute E., Fu, Buyin, Ahove, Deborah, Stevenson, Kristen E., Rajasagi, Mohini, Zhu, Baogong, Alonso, Anselmo, Witten, Elizabeth, Matsuoka, Ken-ichi, Neuberg, Donna, Duke-Cohan, Jonathan S., Wu, Catherine J., Freeman, Gordon J.
フォーマット: Artigo
言語:Inglês
出版事項: Springer-Verlag 2012
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3569584/
https://ncbi.nlm.nih.gov/pubmed/22926059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-012-1331-4
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料